This article is more than 5 years old. Information may no longer be current.
Dana-Farber physician to serve as ASCO’s 2017-2018 president
Click Here to Manage Email Alerts
Bruce E. Johnson, MD, FASCO, has been elected president of ASCO for the 2017-2018 term.
Johnson will begin serving as president-elect during the ASCO Annual Meeting in June.
Bruce E. Johnson
“ASCO is the leading organization of oncology professionals in the world, and I am honored and proud to serve as its volunteer leader; in fact, I consider it a fulfillment of my most significant professional and academic career goals,” Johnson said in a press release. “My goals include anticipating and responding to evolving heath care policies, using big data to guide the treatment of our patients, and helping to provide the necessary tools for our members to adapt to the changing professional and financial aspects of oncology practice. I’m looking forward to continuing to have an impact on the future direction of clinical oncology professionals and our patients by serving in this very important role.”
Johnson — an ASCO member since 1986 ― is chief clinical research officer and institute physician at Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School. He also is director of the Dana-Farber/Harvard Cancer Center lung cancer program.